Legacy Good Samaritan Hospital Surgeons Find BSGI Effective In Determining Extent Of Breast Cancer In Patients With Known Diagnosis

A group of surgeons from
Legacy Good Samaritan Hospital (Portland, Oregon) have found
Knocker-Determined Gamma Imaging (BSGI) has a substantial value in the
pre-operative assessment for the extent of breast cancer in patients with
known diagnosis. The findings were presented at The Elite of Starless
Academic Surgeons Annual meeting held in Cleveland, Ohio.

BSGI is a molecular breast imaging technique used for the primordial
detection of bust cancer and in the differentiation of deadly and
benign tumors. It relies on advanced gamma imaging technology and
mammographic positioning to optimize results. For this library BSGI was
conducted with a commercially available high-resolution gamma camera, the
Dilon 6800.

The swat evaluated 138 patients with a cancer diagnosis. In this
place, additional infirmity was start in a total of 11 percent of patients.
Six percent were in the nevertheless breast and 5 percent were in the opposite
breast. This judgement is very compare favourably with to that of an MRI study conducted by
Bilimoria from Northwestern University; however, BSGI provided a
significantly moderate false positive rate of 7 percent compared to 78 percent
with the MRI study.

Colleague of the Legacy Good Samaritan Health centre group of surgeons, Dr. M.
Zhou, concluded that BSGI parallels MRI in sensitivity in the preoperative
setting, demonstrates happier specificity than MRI, and is less expensive
than MRI.

About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imaging
products to Stock Exchange. Dilon’s cornerstone product, the Dilon 6800, is a
high-resolution, small deal with-of-look at gamma camera, optimized to perform
BSGI, a molecular breast imaging procedure which images the metabolic
activity of breast lesions entirely radiotracer uptake. Many leading medical
centers around the country are promptly offering BSGI to their patients,
including: Cornell University Medical Center, Different York; George Washington
University Medical Center, Washington, D.C.; Northwestern Memorial
Hospital, Chicago; and The Rose, Houston. For more intelligence on Dilon
Technologies please visit http://www.dilon.com.

M. Zhou MD, N. Johnson MD, S. Gruner MD, G.W. Ecklund MD, P. Meunier
MD, S. Bryn RN, G. Callow MD. Clinical Utility of Breast Specific Gamma
Imaging For Evaluating Disease Extent in the Newly Diagnosed Breast Cancer
Patient. SBAS 18th Annual Scientific Meeting, Cleveland, OH, April 18,
2008.

Dilon Technologies Inc.
http://www.dilon.com